Events

How can AI foundation models shorten the cell therapy developments from discovery to human trials?
What role can AI play in reducing cost per dose? Will it help make therapies accessible beyond rare diseases?
How will pharma and AI-native companies collaborate most effectively in the next five years?
 
Join Ajinomoto Group Ventures, Astellas Venture Management, Avant Bio, and Somite AI on November 12 in Boston for a deep dive into AI investing in the cell therapy sector. Enjoy an afternoon connecting with fellow investors and startups over delicious bites and drinks.

Register here